Research Article
Aim & Scope
Aims, Scope, and Audience
Pharmata is a peer-reviewed, open access, online-only journal published by Atatürk University. Pharmata aims to contribute to the scientific literature by publishing manuscripts of the highest caliber. The journal accepts research articles, reviews, and short communications that adhere to ethical guidelines.
The scope of the journal encompasses various topics, including but not limited to:
1. Pharmacognosy
2. Pharmaceutical botany
3. Pharmaceutical technology
4. Pharmacology
5. Pharmaceutical toxicology
6. Analytical chemistry
7. Biochemistry and medical biochemistry
8. Medicinal chemistry
9. Other areas: Health sciences (basic and clinical medical sciences, nursing, pharmaceutical care, etc.), clinical pharmacy, pharmacy management, biotechnology products, engineered cells, food and drug chemistry.
The target audience of the journal includes researchers and specialists who have an interest in or are working in any of the fields covered by the journal's scope.
Indexing
Pharmata is covered in the following indexing database;
• TUBITAK ULAKBIM TR Index
• DOAJ
• EBSCO
• Gale Cengage
• Chemical Abstracts Services (CAS)
To guarantee that all papers published in the journal are maintained and permanently accessible, articles are stored in Dergipark which serves as a national archival web site and at the same time permits LOCKSS to collect, preserve, and serve the content.
Author Guidelines
You can access the Article Submission Guidelines here.
You can access the Article Submission Guidelines video here.
Please download the article template here.
For comprehensive information regarding the journal's policies on submission, peer-review, publication, and ethical standards, kindly visit the Policies page. Similarly, for detailed information about the journal, please visit the Aims and Scope page.
It is strongly advised to review the journal's policies before submitting any manuscripts to ensure compliance with the journal's guidelines.
Manuscripts submitted for evaluation should be original and not previously presented or published in any electronic or print medium. If a manuscript was previously presented at a conference or meeting, authors should provide detailed information about the event, including the name, date, and location of the organization.
Manuscripts should be prepared in accordance with ICMJE-Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (updated in May 2023).
Authors are required to prepare manuscripts in accordance with the relevant guideline listed below:
• Randomized research studies and clinical trials: CONSORT guidelines (for protocols, please see the SPIRIT guidance)
• Observational original research studies: STROBE guidelines
• Studies on diagnostic accuracy: STARD guidelines
• Systematic reviews and meta-analysis: PRISMA guidelines (for protocols, please see the PRISMA-P guidelines)
• Experimental animal studies: ARRIVE guidelines and Guide for the Care and Use of Laboratory Animals, 8th edition
• Nonrandomized evaluations of behavioral and public health interventions: TREND guidelines
• Genetic association studies: STREGA
• Qualitative research: SRQR guidelines
To find the right guideline for your research, please complete the questionnaire by Equator Network here.
Pharmata encourages authors to follow the ‘Sex and Gender Equity in Research – SAGER – guidelines’ when preparing their manuscripts to promote the inclusion of sex and gender considerations in research. Before submission, authors can consult EASE Guidelines for Authors and Translators to produce clear, concise and accurate manuscripts that are easy to understand and free of common errors and pitfalls.
The style of manuscripts should follow the AMA Manual of Style, 11th Edition.
Manuscripts can only be submitted through the journal’s online manuscript submission and evaluation system. Manuscripts submitted via any other medium and submissions by anyone other than one of the authors will not be evaluated.
In addition to the manuscript files, authors are required to submit the following during the initial submission:
· Copyright Agreement and Acknowledgement of Authorship Form, and
· ICMJE Disclosure Form (should be filled in by all contributing authors).
PREPARATION OF THE MANUSCRIPT
Title page: A separate title page should be submitted with all submissions and this page should include:
• The full title of the manuscript as well as a short title (running head) of no more than 50 characters,
• Name(s), affiliations, highest academic degree(s), and ORCID IDs of the author(s),
• Grant information and detailed information on the other sources of support,
• Name, address, telephone (including the mobile phone number), and email address of the corresponding author,
• Acknowledgment of the individuals who contributed to the preparation of the manuscript but who do not fulfill the authorship criteria.
• If the author(s) is a member of the journal’s Editorial Board, this should be specified in the title page.
Abstract: An abstract should be submitted with all submissions except for Letters to the Editor. The abstract of Research Articles should be structured with subheadings (Objective, Methods, Results, and Conclusion). Please check Table 1 below for word count specifications.
Keywords: Each submission must be accompanied by a minimum of three to a maximum of six keywords for subject indexing at the end of the abstract. The keywords should be listed in full without abbreviations. The keywords should be selected from the National Library of Medicine, Medical Subject Headings database (https://www.nlm.nih.gov/mesh/MBrowser.html).
Manuscript Types
Research Articles: Research articles provide new information based on original research. The acceptance of research articles is typically based on the originality and importance of the research. The main text of a Research Article should be structured with subheadings, including Introduction, Methods, Results, Discussion, and Conclusion.
Please check Table 1 for the limitations for Original Articles. You can review the ethical principles flow chart for research articles here.
Clinical Trials
Pharmata adopts the ICMJE's clinical trial registration policy, which requires that clinical trials must be registered in a publicly accessible registry that is a primary register of the WHO International Trials Registry Platform (ICTRP) or in ClinicalTrials.gov. By registering clinical trials in a publicly accessible registry, authors can help to promote transparency and accountability in their research.
Instructions for the clinical trials are listed below.
• Clinical trial registry is only required for the prospective research projects that study the relationship between a health-related intervention and an outcome by assigning people to different groups.
• To have their manuscript evaluated in the journal, authors should register their research to a public registry at or before the time of first patient enrollment.
• Based on most up to date ICMJE recommendations, Pharmata accepts public registries that include minimum acceptable 24-item trial registration dataset.
• Authors are required to state a data sharing plan for the clinical trial registration. Please see details under the “Data Sharing” section.
• For further details, please check ICMJE Clinical Trial Policy and COPE Data and Reproducibility guidelines.
Reporting Statistical Analysis
Statistical analysis to support conclusions is usually necessary. Statistical analyses must be conducted in accordance with international statistical reporting standards (Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J 1983: 7; 1489-93). Information on statistical analyses should be provided with a separate subheading under the Materials and Methods section and the statistical software that was used during the process must be specified.
When reporting statistical data in a research paper, it is important to present the values in a clear and consistent manner. P values, confidence intervals (CIs), and other statistical measures should be rounded appropriately and expressed according to the guidelines provided. For example, P values should be expressed to two digits to the right of the decimal point unless the first two digits are zeros, in which case three digits should be provided (eg, instead of P < .01, report as P = .002). However, values close to .05 may be reported to three decimal places because .05 is an arbitrary cut-off point for statistical significance (eg, P = .053). P values less than .001 should be designated as P < .001 rather than providing the exact value (eg, P = .000006).
Units should be prepared in accordance with the International System of Units (SI).
Review Articles
Review articles that are written by authors with extensive knowledge and expertise in a particular field and a strong track record of publication are welcomed. These authors may even be invited to contribute a review article to the journal. Review articles should provide a comprehensive overview of the current state of knowledge on a topic in clinical practice, and should include discussions and evaluations of relevant research. The subheadings of the review articles can be planned by the authors. However, each review article should include an “Introduction” and a “Conclusion” section. Please check Table 1 for the limitations for Review Articles.
Short Communications
Short Communications are brief, focused articles that present new scientific research or theories. These articles should be written in the same format as a full-length original research article, with sections for Introduction, Materials and Methods, Results, and Discussion. The total length of the article should not exceed 2500 words, with a 150-word abstract and a maximum of 3 display items (figures/tables). Please refer to Table 1 for the limitations for “Short Communications.”
Table 1. Limitations for each manuscript type
| Type of manuscript | Word limit* | Abstract word limit | Reference limit | Table limit | Figure limit |
| Research Article | 8000 | 200-300 | 70 | 6 | 5 or total of 10 images |
| Review Article | 5000 | 200-300 | 70 | 6 | 10 or total of 15 images |
| Short Communications | 2500 | 150 | 15 | 3 | 3 images |
*Word limit should not include the abstract, references, tables, and figure legends.
Tables
Tables should be included in the main document, after the reference list, and they should be numbered consecutively in the order they are referred to within the text. Each table should have a descriptive title placed above it, and any abbreviations used in the table should be defined below the table by footnotes (even if they are defined in the main text). Tables should be created using the "insert table" command of the Word processing software, and they should be arranged clearly to make the data easy to read and understand. The data presented in the tables should not be a repetition of the data presented in the main text, but should support and enhance the main text.
Figures and Figure Legends
Figures should be submitted as separate files in TIFF or JPEG format, and they should not be embedded in the Word document or the main manuscript file. If a figure has subunits, each subunit should be submitted as a separate file, and the subunits should not be merged into a single image. The figures should not be labeled (a, b, c, etc.) to indicate subunits. Instead, the figure legend should be used to describe the different parts of the figure. Thick and thin arrows, arrowheads, stars, asterisks, and similar marks can be used on the images to support figure legends.Images should be anonymized to remove any information that may identify individuals or institutions. The minimum resolution of each figure should be 300 DPI, and the figures should be clear and easy to read. Figure legends should be listed at the end of the main document. Figures should be referred to within the main text, and they should be numbered consecutively in the order in which they are mentioned.
Abbreviations
All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and in the main text. The abbreviation should be provided in parentheses following the definition, and it should be used consistently throughout the paper.
Identifying products
When mentioning a drug, product, hardware, or software program in a manuscript, it is important to provide detailed information about the product in parentheses. This should include the name of the product, the producer of the product, and the city and country of the company. For example, if mentioning a Discovery St PET/CT scanner produced by General Electric in Milwaukee, Wisconsin, USA, the information should be presented in the following format: "Discovery St PET/CT scanner (General Electric, Milwaukee, WI, USA)." Providing this information helps to ensure that the product is properly identified and credited.
Supplementary Materials
Supplementary materials, including audio files, videos, datasets, and additional documents (e.g., appendices, additional figures, tables), are intended to complement the main text of the manuscript. These supplementary materials should be submitted as a separate section after the references list. Concise descriptions of each supplementary material should be included to explain their relevance to the manuscript. Page numbers are not required for supplementary materials.
References
Both in-text citations and the references must be prepared according to the AMA Manual of Style 11th Edition.
When citing publications, preference should be given to the latest, most up-to-date sources. Citing the latest sources can help to ensure that the paper is relevant and timely, and that it reflects the latest developments in the field.
It is the responsibility of the authors to ensure the accuracy of the references in their article. All sources must be properly cited, and the citations must be formatted correctly.
In the main text of the manuscript, references should be cited in superscript after punctuation.
If an ahead-of-print publication is cited, the DOI number should be provided in the reference list.
Journal titles should be abbreviated in the reference list in accordance with the journal abbreviations in Index Medicus/MEDLINE/PubMed.
When there are six or fewer authors, all authors should be listed. If there are seven or more authors, the first three authors should be listed followed by “et al.” in the reference list.
The reference styles for different types of publications are presented in the following examples.
Journal Article: Ammitzboll C, Andersen JB, Vils SR, et al. Isolation, behavioral changes, and low seroprevalence of SARS-CoV-2 antibodies in patients with systemic lupus erythematosus or rheumatoid arthritis. Arthritis Care Res. 2022;74(11):1780-1785.
Book Section: Cohen EL. The multidisciplinary, interdisciplinary, and transdisciplinary nature of health communication scholarship. In: Thompson TL, Harrington NG, eds. The Routledge Handbook of Health Communication. London: Routledge;2022:3-16.
Books with a Single Author: Haslwanter T. An Introduction to Statistics with Python. 2nd ed. New York, NY: Springer International Publishing; 2022.
Editor(s) as Author: Thompson TL, Harrington NG, eds. The Routledge Handbook of Health Communication. London: Routledge;2022.
Thesis: Chunga A. The Role of the Gastrointestinal Tract Microbiota in Colonisation Resistance Against Common Enteric Pathogens in Malawian Children. Dissertation. University of Liverpool; 2022.
Websites: International Society for Infectious Diseases. ProMed-mail. Accessed December 13, 2022. http://www.promedmail.org
Epub Ahead of Print Articles: Torres X, Bennasar M, Bautista-Rodríguez C, et al. The heart after surviving twin-to-twin transfusion syndrome. Am J Obstet Gynecol. 2022 Mar 26. doi: 10.1016/j.ajog.2022.03.049. [Epub ahead of print].
PRODUCTION
Once a manuscript has been accepted for publication, it goes through a copy-editing process by professional language editors to ensure that it is clear and well-written. This process may involve correcting grammar, punctuation, and formatting errors, as well as making changes to improve the overall clarity and readability of the manuscript.
After the copy-editing process is complete, the manuscript is published online as an "ahead-of-print" publication, which means that it is available to readers before it is included in a scheduled issue of the journal. This allows readers to access the latest research as soon as it becomes available.
Before the manuscript is officially published, the corresponding author is sent a PDF proof of the accepted manuscript for review. The corresponding author is asked to review the proof and approve it for publication within a specified time period, typically 2 days. This is an important step in the publication process, as it allows the author to catch any errors or make any final changes before the manuscript is published.
Ethical Principles and Publication Policy
Price Policy
Pharmata is funded by the Atatürk University. Authors are not required to pay any fees during the evaluation and publication process.
Indexes
Citation Indexes
Other Indexes
Journal Boards
Editor
After graduating in 1983 from Atatürk University, Faculty of Science, Department of Chemistry, he completed his Master's and Doctorate between 1983-1990. He became Assistant Professor in 1990 and Associate Professor in 1997. In 1999, he started to work as an Associate Professor in the Department of Analytical Chemistry, Faculty of Pharmacy. In 2003, he became a Professor. His research interests are: Method Development and Validation of Active Pharmaceutical Ingredient Analysis in Various Media, Spectroscopic Methods, Chromatographic Methods, Chemometric Methods and Metabolomics.
Translated with DeepL.com (free version)
Section Editors
Evli ve 1 kız çocuğu babasıyım. Lisans eğitimimi 2012 yılında Atatürk Üniversitesi Eczacılık Fakültesinde, Doktora eğitimimi ise 2016 yılında Atatürk Üniversitesi Sağlık Bilimleri Enstitüsü Tıbbi Farmakoloji Ana Bilim Dalında tamamladım. 2010-2011 yılları arasında Fransa Lille Droit et Sante Üniversitesinde Erasmus Öğrencisi olarak bulundum. 5 yıl kadar Toplum eczacılığı yaptıktan sonra 2017 yılında Atatürk Üniversitesi Eczacılık Fakültesi Farmakoloji Ana Bilim Dalına Yardımcı Doçent olarak atandım. 2021 yılında Doçent unvanımı aldım. Halen Atatürk Üniversitesi Eczacılık Fakültesinde Doçent olarak görev yapmaktayım. 2021 yılından itibaren Eczacılık Fakültesi Dekan yardımcılığı ve Klinik eczacılık Ana Bilim Dalı Başkanlığını görevlerini yürütmekteyim. Tıbbi Farmakoloji ve Klinik Eczacılık Lisansüstü programlarında toplam 4 adet doktora, 5 adet yüksek lisans öğrencisine danışmanlık yapmaktayım. WOS'ta taranan 26'sı SCI toplam 32 makalem bulunmaktadır. WOS H indeksim 13'dür. 5 adet TR Dizin makalem bulunmaktadır. Bir kitapta editör, 5 kitapta ise bölüm yazarlığım vardır. Bir çok BAP ve TÜBİTAK projesinde yürütücü ve araştırmacı olarak görev yaptım ve bazıları halen devam etmektedir. Ulusal/uluslararası kongrelerde toplam 16 bildirim bulunmaktadır. Bir çok kongre ve çalıştayda düzenleme kurulu başkanı, başkan yardımcısı ve üyesi olarak görevler aldım. Türk Eczacıları Birliği, Türk Farmakoloji Derneği ve Türk Biyokimya Derneğine üyeliklerim bulunmaktadır.
Çok Disiplinli Bilimler, Temel Bilimler (Sci), Doğa Bilimleri Genel, Farmakoloji Ve Eczacılık, Kimya, Biyoloji Ve Biyokimya, Biyoloji, Kimya Organik, Yaşam Bilimleri (Life), Spektroskopi, Farmakoloji Ve Toksikoloji
1994 yılında Hacettepe Üniversitesi Eczacılık Fakültesi’nden mezun olmuştur. Farmasötik teknoloji alanında Hacettepe Üniversitesi’nde yüksek lisans, Hacettepe Üniversitesi ve Paris Sud Üniversite’lerinde doktora yapmıştır. 1994 yılından itibaren Hacettepe Üniversitesi, T.C. Sağlık Bakanlığı İlaç ve Eczacılık Genel Müdürlüğü ve Atatürk Üniversitesi Eczacılık Fakültesi’nde görev yapmıştır. 2010 yılından beri Erciyes Üniversitesi Eczacılık Fakültesi Farmasötik Teknoloji Anabilim Dalı öğretim üyesidir.
Technical Editors
Language Editors
Statistics Editor
Editorial Board
Doktora, Ege Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya, Türkiye 1991 -1996
Yüksek Lisans, Ege Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya, Türkiye 1989 -1991
Lisans, Ege Üniversitesi, Eczacılık Fakültesi, Türkiye 1984 -1988
I am a faculty member at the Department of Pharmacognosy at Atatürk University, Faculty of Pharmacy. My field of study is the chemical composition and pharmacological effects of medicinal and aromatic plants. I have been continuing my research on this subject since 2000.
Dr. Bashar Alkhalidi holds aPh.D. degree in Industrial Pharmacy from UCM in Spain with an honor degree, he currently works as an Associate professor of Pharmaceutics and Drug Delivery at p the University of Jordan. Jordanian FDA. i g y Dr. Alkhalidi has participated actively in community service through working with Jordanian FDA Dr. Alkhalidi works as Consultant and Trainer to the local and regional pharmaceutical industry in field of dosage form development, quality g p q y management and GMP inspection. Dr. Alkhalidi has many scientific publications in the field of pharmaceutics, formulation and drug delivery. Recently he accomplished a project with PwC as Recently he accomplished a project with PwC as a SME.
1957 yılında Burdur’da doğdu. İlk ve orta öğrenimini Antalya’da tamamladı. Ankara Üniversitesi Eczacılık Fakültesi’ni (1979) bitirdi. Anadolu Üniversitesi Sağlık Bilimleri Enstitüsü’nde Farmasötik Kimya Doktoru oldu (1985). 1989 yılında doçent, 1996 yılında profesör oldu. Anadolu Üniversitesi Eczacılık Fakültesi’nde Farmasötik Kimya Anabilim Dalı Başkanlığı (1998-2003 ve 2008-2010), Eczacılık Meslek Bilimleri Bölümü Başkanlığı (2002-2007) ve Anadolu Üniversitesi Sağlık Bilimleri Enstitüsü Müdürlüğü (2010) görevlerinde bulundu. 2012 yılından beri TÜBA asil üyesidir.
CV of Prof. Hasan Küçükbay
H. Küçükbay was born in Yeşilyurt-Malatya, TURKEY. He received his BS degree from the University of Inönü (valedictorian), Malatya, Turkey in 1985, and He graduated with a MSc and a PhD in organic chemistry from the University of Inönü in 1988 and 1993, respectively. He worked for one year as researcher at Professor Michael F. Lappert's research laboratory at University of Sussex, UK in 1991-1992, six weeks as researcher at Professor Pierre H. Dixneuf’s research laboratory at University of Rennes1, France in 1995, three months as research scholar at Professor Alan R. Katritzky’s reserach laboratory at University of Florida, Gainswille, USA in 2012 and four months as visitor researcher at Professor Claudiu T. Supuran’s reserach laboratory at University of Florence, Firenze, Italy in 2015 and 2018. He has been to University of Crete-GR in 2007 and RWTH-Aachen-GER for a short time in 2008 within the framework of the Erasmus Project. He received his Associate Professor degree from the Turkish Council of Higher Education in 1997. He received his Professor degree from İnönü University in 2003. His research interests have been in electron-rich olefins, their carbenmetal complexes and catalytic properties such as cyclisation and Suzuki, Heck and Sonogashira C-C cross coupling reactions, synthesis and biological properties of peptide and their conjugates, synthesis of heterocyclic compounds, particularly benzimidazole and benzothiazole derivatives and their microbiological properties. He has over 100 scientific articles in SCI/SCI-Exp covered journals and one patent. He chaired the 5th International Organic Chemistry Congress held in Malatya-Turkey in 2021. He acts as Editor-in Chief of Journal of the Turkish Chemical Society, Section A: Chemistry (JOTCSA) and Associate Editor Frontiers in Organic Chemistry. He has been working since 1986 at University of Inönü. He is married with two sons.
Address: İnönü University, Faculty of Sciences and Arts, Chemistry Department, 44280 Malatya-TURKEY
E-mail: hasan.kucukbay@inonu.edu.tr
ORCID:0000-0002-7180-9486
Web of Science Research ID: A-5050-2019
Scopus ID: 6701563510
Meltem Çetin, Atatürk Üniversitesi, Eczacılık Fakültesi, Farmasötik Teknoloji AD’nda Profesör olarak görev yapmaktadır. Nano-boyutlu ilaç taşıyıcı sistemler konusunda çalışmaktadır ve yaklaşık 20 yıldır Atatürk Üniversitesi'nde ders vermektedir. SCIE'de indekslenen dergilerde yayınlanmış 34 makalesi bulunmaktadır ve çok sayıda bilimsel araştırma projesinde proje yürütücüsü veya araştırmacı olarak görev almıştır.
PostDoktora,Universitaet Innsbruck,Biochemica,Avusturya 2015 -2015
PostDoktora,University ofOxford,Pharmacology,BirleşikKral ık2014 -2014
Doktora,AtatürkÜniversitesi,SağlıkBilimleriEnstitüsü,TıbbiFarmakoloji,Türkiye 2009 -2012
YüksekLisans,AtatürkÜniversitesi,SağlıkBilimleriEnstitüsü,FarmasötikToksikoloji,Türkiye 2006 -2009
Lisans,AtatürkÜniversitesi,EczacılıkFakültesi,Türkiye 2002 -2006
Professor A. C. Calokerinos received his B.Sc. in Chemistry from the Department of Chemistry of the National and Kapodistrian University of Athens. He continued for postgraduate studies at the University of Birminghan, United Kingdom, for the degrees of Master of Science (M.Sc.) in Analytical Chemistry and Doctor of Philosophy (Ph.D.) in Chemistry (Analytical Chemistry) under the supervision of Professors R. Belcher and A. Townshend. He has also visited the University of Hull, United Kingdom for postdoctoral studies.
Professor A. C. Calokerinos is a member of the staff of the Laboratory of Analytical Chemistry of the Department of Chemistry of the National and Kapodistrian University of Athens. since 1981. He has served as Deputy Chairman (2003-2005 and 2007-2009) and Chairman (2009-2011 and 2011 - 2013) and Director of Section I (2005- 2007) of the Department of Chemistry.
His teaching duties at the undergraduate level include Analytical Chemistry (lectures and laboratory practice) for first year and Current Analytical Techniques for final year students of the Department of Chemistry. At the postgraduate level, he is the coordinator of the postgraduate course ANALYTICAL CHEMISTRY and gives lectures on Statistical treatment of Analytical results and Advanced Analytical Chemistry. He also participates in the postgraduate course CHEMICAL ANALYSIS – QUALITY CONTROL where he gives lectures on Chemical Instrumentation, Advanced Analytical Chemistry and Quality Control of Packaging Material.
Main research interests
• Chemiluminescence and bioluminescence
• ozone chemiluminescence and ozone reactions
• flame chemiluminescence (molecular emissions), emission methods of analysis
• halogenated solvents and substitution
• applications of gas and liquid chromatography
• ion selective electrodes
• analytical techniques in quality control of natural products
• development of new analytical methods and techniques
Ethical Editor
Content of this journal is licensed under a Creative Commons Attribution NonCommercial 4.0 International License